» Journals » Eur Heart J Suppl

European Heart Journal Supplements : Journal of the European Society of Cardiology

European Heart Journal Supplements : Journal of the European Society of Cardiology is a scientific journal, published by Oxford University Press since 1999 in English. The journal's country of origin is United Kingdom.

Details
Abbr. Eur Heart J Suppl
Start 1999
End Continuing
Frequency Irregular
p-ISSN 1520-765X
e-ISSN 1554-2815
Country United Kingdom
Language English
Metrics
h-index / Ranks: 8575 41
SJR / Ranks: 9249 477
CiteScore / Ranks: 8179 3.20
JIF / Ranks: 5932 1.6
Recent Articles
1.
Mushtaq S, Fazzari F, Mancini M, Pontone G
Eur Heart J Suppl . 2025 Feb; 27(Suppl 1):i22-i26. PMID: 39980793
Coronary computed tomography angiography (CCTA) is the first-line investigation test to 'rule out' significant coronary artery disease in low-risk patients. By performing blood flow simulations using computational fluid dynamics, it...
2.
Schwartz P, Dagradi F, Giovenzana F, Cerea P
Eur Heart J Suppl . 2025 Feb; 27(Suppl 1):i47-i50. PMID: 39980792
This essay stems from a controversial recommendation present in the 2022 European Guidelines which indicated the appropriateness of considering an implantable cardioverter defibrillator (ICD) implant even for still asymptomatic long...
3.
Rebecchi M, De Ruvo E, Sette A, Grieco D, De Luca L, Strano S, et al.
Eur Heart J Suppl . 2025 Feb; 27(Suppl 1):i171-i176. PMID: 39980791
Cardioneuroablation (CNA) is now recognized as a safe and effective method in patients with cardioinhibitory neurocardiogenic syncope (CNCS), especially in young patients in order to avoid or prolong, as much...
4.
Lorenzoni G, Merella P, Casu G
Eur Heart J Suppl . 2025 Feb; 27(Suppl 1):i12-i15. PMID: 39980790
Atrial fibrillation (AF) is the most common arrhythmia in adults and is associated with an increased risk of embolic stroke. The main prevention strategy for cerebral embolic events is based...
5.
De Caterina R, Chiusolo S
Eur Heart J Suppl . 2025 Feb; 27(Suppl 1):i6-i11. PMID: 39980789
Over the past decade, non-vitamin K antagonist oral anticoagulants have revolutionized anticoagulation therapy, offering substantial benefits over traditional vitamin K antagonists. Non-vitamin K antagonist oral anticoagulants offer reduced bleeding risks,...
6.
Mazzanti A, Kukavica D, Trancuccio A, Scilabra G, Coppini L, Pergola V, et al.
Eur Heart J Suppl . 2025 Feb; 27(Suppl 1):i98-i102. PMID: 39980788
Advances in understanding the genetic architecture and novel imaging techniques have profoundly impacted research on arrhythmogenic right ventricular cardiomyopathy (ARVC). As knowledge of ARVC has evolved, so has its classification:...
7.
Urtis M, Tagliani M, Bondavalli D, Paganini C, Cavaliere C, Vilardo V, et al.
Eur Heart J Suppl . 2025 Feb; 27(Suppl 1):i67-i72. PMID: 39980787
The diagnostic work-up of cardiovascular genetic diseases is emerging as a reference model for precision (cause and phenotype) and personalized medicine (tailored individual management). This approach is expanding across all...
8.
Castiglione V, Montuoro S, Orlando G, Aimo A, Vergaro G, Emdin M
Eur Heart J Suppl . 2025 Feb; 27(Suppl 1):i88-i97. PMID: 39980786
Cardiac amyloidosis (CA) is a progressive, underdiagnosed condition caused by the deposition of misfolded proteins in the myocardium, forming amyloid fibrils that impair cardiac structure and function. This review highlights...
9.
Cice G, Calo L
Eur Heart J Suppl . 2025 Feb; 27(Suppl 1):i149-i153. PMID: 39980785
The 'chronic kidney disease' (CKD) definition that best outlines the complex syndrome commonly called 'kidney failure' has become a problem of World Public Health due to its incidence and prevalence...
10.
Panattoni G, Desimone P, Toto F, Meringolo F, Jacomelli I, Rebecchi M, et al.
Eur Heart J Suppl . 2025 Feb; 27(Suppl 1):i16-i21. PMID: 39980784
Cardiovascular diseases (CVDs) remain a major cause of morbidity and mortality worldwide. The European Society of Cardiology Guidelines encourage the use of risk prediction models to enhance an adequate management...